Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Ebastine Versus Mebeverine in IBS Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ebastine versus mebeverine in patients with irritable bowel syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebastine (ebastine)
  • Mebeverine (mebeverine)

Snippet

Sponsor: Guy Boeckxstaens | Conditions: IBS - Irritable Bowel Syndrome, IBS | Phase 3 | Status: RECRUITING